Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
Where this comes from
- Record sourced from PubMed, PMID 29630687.
- Also identified by DOI 10.1001/jamainternmed.2018.0776 and PMC identifier 6145757.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines the association between oncologists’ receipt of payments from pharmaceutical manufacturers and drug selection in 2 situations where there are multiple treatment options.
Medical subject headings
- Antineoplastic Agents
- Drug Industry
- Practice Patterns, Physicians'